BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

90 hedge funds and large institutions have $38.5M invested in BRAINSTORM CELL THERAPUTC in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 18 closing their positions.

Holders
90
Holders Change
+10
Holders Change %
+12.5%
% of All Funds
1.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
27
Reduced
20
Closed
18
Calls
$4.5M
Puts
$5.17M
Net Calls
-$668K
Net Calls Change
+$19.5M

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$1.78M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$1.68M
3
Voloridge Investment Management
3
Voloridge Investment Management
Florida
$1.62M
4
PF
4
Phoenix Financial
Israel
$799K
5
Morgan Stanley
5
Morgan Stanley
New York
$964K

Top Sellers

1
Invesco
1
Invesco
Georgia
$0
2
EI
2
EAM Investors
California
$0
3
State of Wisconsin Investment Board
3
State of Wisconsin Investment Board
Wisconsin
$0
4
WG
4
Winton Group
United Kingdom
$54K
5
SG Americas Securities
5
SG Americas Securities
New York
$68K
Name Holding Trade Value Shares
Change 		Shares
Change %
DWA
101
Dorsey Wright & Associates
California
– -$19K -75 Closed
ASN
102
Advisory Services Network
Georgia
– -$12K -47 Closed
Federated Hermes
103
Federated Hermes
Pennsylvania
– -$5K -21 Closed
GAM
104
Gemmer Asset Management
California
– -$3K -13 Closed
GWM
105
Geneos Wealth Management
Colorado
– -$1K -7 Closed
1 2 3 4
5